Beckman Coulter’s DxI 9000 Immunoassay Analyzer Extends Menu with New CE-Marked Hepatitis Assays at ESCMID Global
Beckman Coulter Diagnostics, a leader in clinical diagnostics, announced today, ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global), that it has extended the menu of DxI 9000 Immunoassay Analyzer* assays. Recently, tests…
DDRC Agilus Diagnostics, a unit of Agilus Diagnostics Ltd. Launches Largest 24×7 Reference Laboratory and Wellness Center in Kottayam
DDRC Agilus Diagnostics (a subsidiary of Agilus Diagnostics Limited), today announced the launch of their regional wellness center and laboratory in Kottayam. This wellness centre and laboratory will serve as a reference lab further strengthening the existing network of 35…
Sunrise Oncology Centre Introduces Comprehensive Cancer Care in Vasai, a First for Palghar District
Sunrise Oncology Centre, a leading provider of comprehensive cancer care, is proud to announce the opening of its new facility in Vasai, marking the establishment of the first cancer registry in Palghar district. The new centre aims to provide holistic…
Pharmactive Presents Affron® Saffron Gummies and Aged Black Garlic
Catering to the world of natural wellness, Pharmactive Biotech Products, SLU will showcase two premier clean-label botanical ingredients: affron® saffron extract and ABG+®, aged black garlic. Both are prominent examples of innovative products designed to improve quality of life. On…
DIGITAL THERAPEUTICS STARTUP RESPIREE™ ANNOUNCES INCORPORATION IN US WITH RESIDENCY AT JLABS @ SAN FRANCISCO
Respiree announced today that it has incorporated in the US and will be incubating within Johnson & Johnson Innovation – JLABS @ South San Francisco[1] from February 12, 2024. By expanding footprint within the US, Respiree aims to deepen its relationships and networks…
TreeFrog Presents Data from Its Parkinson’s Cell Therapy Program
TreeFrog Therapeutics, a cell therapy development company with its leading Parkinson’s disease program, is presenting for the first time at the annual meeting of the American Academy of Neurology, which will take place in Denver, Colorado from April 13-18, 2024. Parkinson’s disease…
EVERSANA Completes Integration of Healthware Group and Strengthens Its Global Agency Network EVERSANA INTOUCH With Addition of New Full-Service Affiliate
EVERSANA, a leading provider of global commercial services to the life sciences industry, today unveiled a new full-service affiliate in its EVERSANA INTOUCH global agency network, EVERSANA INTOUCH Healthware. Today’s announcement comes following the October 2023 acquisition of Healthware Group, an agency and innovation consultancy headquartered…
Gedeon Richter: Cariprazine Proves Effective in Treating Dual Diagnosis
New analyses of cariprazine studies were presented by Gedeon Richter Plc. at 32e Annual Congress of the European Psychiatric Association held April 6-9 in Budapest, Hungary. According to scientific posters of the event, cariprazine could be an appropriate treatment not only for…
A New Generation of Antidepressant Drug Precision Treatment Based on Revolutionary AI Technology is Born
The9 Limited (Nasdaq: NCTY) (“The9”), an established Internet company, today announced that its investee WM Therapeutics Co., Ltd. (未名脑脑) (“WM Therapeutics”) has achieved revolutionary breakthroughs in the proprietarily developed research and development of antidepressant drug precision treatment. WM Therapeutics’ GenAI multi-dimensional omics…
PHAXIAM Therapeutics announces enrolment of the first patient in the phase 1 study for the treatment of endocarditis infections caused by Staphylococcus aureus
PHAXIAM Therapeutics (Nasdaq & Euronext: FR0011471135), today announces the enrolment of the 1st patient in the phase 1 clinical study in endocarditis infection caused by Staphylococcus aureus (S. aureus). Endocarditis is an infection of the endocardium (inner lining of the…
